Evidence map›Paper›PMID 24651452›Full record

ArticleMolecular cancer research : MCR2014

Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.

Melanie A Krook, Lauren A Nicholls, Christopher A Scannell, Rashmi Chugh, Dafydd G Thomas, Elizabeth R Lawlor

Open access · greenAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Expression of CXCR4 on CD4Frontiers in psychiatry · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Role of immunotherapy in Ewing sarcoma.Journal for immunotherapy of cancer · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Melanie A KrookAuthors' Affiliations: Departments of Pediatrics and Communicable Diseases.
Lauren A NichollsAuthors' Affiliations: Departments of Pediatrics and Communicable Diseases.
Christopher A ScannellAuthors' Affiliations: Departments of Pediatrics and Communicable Diseases.
Rashmi ChughInternal Medicine, and.
Dafydd G ThomasPathology, University of Michigan, Ann Arbor, Michigan.
Elizabeth R LawlorAuthors' Affiliations: Departments of Pediatrics and Communicable Diseases, Pathology, University of Michigan, Ann Arbor, Michigan elawlor@med.umich.edu.
University of Michigan–Ann Arbor · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Tissue and Pathology ResourcesU54CA168512 · NCI · SARC · PI POLLOCK, RAPHAEL E. · 2012 to 2016
$11.0M
Training Program in Molecular HematologyT32HL007622 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUNG WON CHOI, Jordan A. Shavit · 1986 to 2026
$9.2M
Diagnostic and Prognostic Sarcoma SignaturesU01CA114757 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI TRICHE, TIMOTHY J. · 2005 to 2009
$8.5M
Training Program in Tumor MicroenvironmentT32CA009676 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, Analisa Virginia DiFeo · 1992 to 2026
$7.3M
PEDIATRICS TRAINING: CELLULAR AND MOLECULAR BIOLOGYT32HD007513 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GILSDORF, JANET R · 1998 to 2012
$3.6M
NCI NIH HHS 1U01-CA114757NCI NIH HHS P30 CA046592NCI NIH HHS P30 CA046592)NCI NIH HHS T32 CA009676NCI NIH HHS U01 CA114757NCI NIH HHS U54 CA168512NHLBI NIH HHS 5T32HL007622NHLBI NIH HHS T32 HL007622NICHD NIH HHS 5T32HD007513NICHD NIH HHS T32 HD007513
6 · The paper itself

Abstract

unlabelledEwing sarcoma is the second most common bone cancer in pediatric patients. Although the primary cause of death in Ewing sarcoma is metastasis, the mechanism underlying tumor spread needs to be elucidated. To this end, the role of the CXCR4/SDF-1a chemokine axis as a mediator of Ewing sarcoma metastasis was investigated. CXCR4 expression status was measured in primary tumor specimens by immunohistochemical staining and in multiple cell lines by quantitative reverse transcriptase PCR and flow cytometry. Migration and invasion of CXCR4-positive Ewing sarcoma cells toward CXCL12/SDF-1a were also determined. Interestingly, while CXCR4 status was disparate among Ewing sarcoma cells, ranging from absent to high-level expression, its expression was found to be highly dynamic and responsive to changes in the microenvironment. In particular, upregulation of CXCR4 occurred in cells that were subjected to growth factor deprivation, hypoxia, and space constraints. This upregulation of CXCR4 was rapidly reversed upon removal of the offending cellular stress conditions. Functionally, CXCR4-positive cells migrated and invaded toward an SDF-1a gradient and these aggressive properties were impeded by both the CXCR4 small-molecule inhibitor AMD3100, and by knockdown of CXCR4. In addition, CXCR4-dependent migration and invasion were inhibited by small-molecule inhibitors of Cdc42 and Rac1, mechanistically implicating these Rho-GTPases as downstream mediators of the CXCR4-dependent phenotype. IMPLICATIONS: This study reveals the highly plastic and dynamic nature of CXCR4 expression in Ewing sarcoma and supports a model in which stress-induced upregulation of CXCR4 contributes to tumor metastasis to lung and bone marrow, which express high levels of SDF-1a.

Indexed as

Bone Neoplasmscdc42 GTP-Binding ProteinCell Growth ProcessesCell HypoxiaCell Line, TumorCell MovementChemokine CXCL12Gene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansNeoplasm Invasivenessrac1 GTP-Binding ProteinReceptors, CXCR4Sarcoma, EwingStress, Physiologicalcdc42 GTP-Binding ProteinChemokine CXCL12CXCL12 protein, humanrac1 GTP-Binding ProteinRAC1 protein, humanReceptors, CXCR4

Identifiers

PMID24651452
PMCPMC4058379
OpenAlexW2119949798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.